Efficacy of Adjuvant Carboplatinum-Epirubicin Chemotherapy in Advanced Ovarian Cancer after Radical Surgery
H. Pickel(University of Graz), M. Lehnert(Merck & Co., Inc., Rahway, NJ, USA (United States)), H. Stettner, M. Lahousen(University of Graz), Edgar Petru(Medical University of Graz)
Cited by 3
Related Papers
Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
|Clinical Cancer Research|2015|799
Inferring expressed genes by whole-genome sequencing of plasma DNA
|Nature Genetics|2016|463
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.
|PubMed|1996|388
Clinical multidrug resistance in cancer: A multifactorial problem
|European Journal of Cancer|1996|178